|
Novel Phosphorylation that Controls the Stability of Hypoxia-Inducible Factor 1 Alpha
This invention relates to a polyclonal antibody against a novel phosphorylation site that is known to be correlated with increased tumor growth. Specifically, the antibody targets a phosphorylation site on HIF-1α which is controlled by PIM kinases. This invention can be used not only as a therapeutic against cancer but also potentially as a means...
Published: 4/3/2023
|
Inventor(s): Noel Warfel
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Medical Devices > Diagnostic
|
